Rhythm Pharmaceuticals (RYTM) Treasury Shares (2016 - 2025)
Rhythm Pharmaceuticals (RYTM) reported Treasury Shares of $194419.0 for Q4 2025, down 22.02% year-over-year from $249322.0 in Q4 2024, and down 22.02% quarter-over-quarter from $249322.0 in Q4 2024.
Rhythm Pharmaceuticals (RYTM) Treasury Shares (2016 - 2025) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 8 years of Treasury Shares data on file, last reported at $194419.0 in Q4 2025.
- Treasury Shares for Q4 2025 came in at $194419.0, down 22.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $194419.0 (down 22.02% YoY), and the FY2025 annual result was $194419.0, down 22.02% from the prior year.
- Treasury Shares retreated to $194419.0 in Q4 2025 per RYTM's latest filing, from $249322.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.1 million in Q4 2023 and troughed at $194419.0 in Q4 2025.
- A 5-year average of $655731.8 and a median of $774166.0 in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2024: Treasury Shares surged 441.61% in 2021, then plunged 77.43% in 2024.
- A 5-year view of Treasury Shares shows it stood at $956145.0 in 2021, then retreated by 19.03% to $774166.0 in 2022, then surged by 42.68% to $1.1 million in 2023, then sank by 77.43% to $249322.0 in 2024, then decreased by 22.02% to $194419.0 in 2025.
- Business Quant data shows RYTM's Treasury Shares at $194419.0 in Q4 2025, $249322.0 in Q4 2024, and $1.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 194,419.00 |
| Dec 31, 2025 | 194,419.00 |
| Dec 31, 2024 | 249,322.00 |
| Dec 31, 2024 | 249,322.00 |
| Dec 31, 2023 | 1.10 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 774,166.00 |
| Dec 31, 2022 | 774,166.00 |
| Dec 31, 2021 | 956,145.00 |
| Dec 31, 2021 | 956,145.00 |
| Dec 31, 2020 | 176,537.00 |
| Dec 31, 2020 | 176,537.00 |
| Dec 31, 2017 | 23,569.00 |
| Dec 31, 2017 | 23,569.00 |
| Dec 31, 2016 | 94,617.00 |
| Dec 31, 2016 | 94,617.00 |